HAACW / Health Assurance Acquisition Corp - Warrants(12/11/2025) - Documents déposés auprès de la SEC, rapport annuel, procuration

HAACU / Health Assurance Acquisition Corp. SAIL Securities / STAD MARC - SC 13G/A Passive Investment

SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1) * HEALTH ASSURANCE ACQUISITION CORP. (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 42226W208** (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this Statement) Check the

HAAC / Health Assurance Acquisition Corp / Atlas Merchant Capital LLC - AMENDMENT NO. 1 Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Health Assurance Acquisition Corp. (Name of Issuer) Class A Common Stock, $0.0001 par value per share (Title of Class of Securities) 42226W109 (CUSIP Number) November 18, 2022 (Date of Event which Requires Filing of this Statement) Check the appropriate

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

OMB APPROVAL UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OMB Number: 3235-0167 Expires: July 31, 2024 Estimated average burden hours per response: 1.50 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT

HAAC / Health Assurance Acquisition Corp / Atlas Merchant Capital LLC - SCHEDULE 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Health Assurance Acquisition Corp. (Name of Issuer) Class A Common Stock, $0.0001 par value per share (Title of Class of Securities) 42226W109 (CUSIP Number) October 28, 2022 (Date of Event which Requires Filing of this Statement) Check the appropriate bo

Health Assurance Acquisition Corp. will redeem its Public Shares and will not consummate an initial business combination

Exhibit 99.1 Health Assurance Acquisition Corp. will redeem its Public Shares and will not consummate an initial business combination Cambridge, Massachusetts, October 27, 2022 – Health Assurance Acquisition Corp. (the “Company”) (Nasdaq: HAAC), a special purpose acquisition company, today announced that as of the close of business on November 3, 2022, the Company’s publicly held Class A ordinary

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 27, 2022 HEALTH ASSURANCE

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 27, 2022 HEALTH ASSURANCE ACQUISITION CORP. (Exact name of registrant as specified in its charter) Delaware 001-39702 85-2899745 (State or other jurisdiction of incorporation)

Health Assurance Acquisition Corp. Releases Letter to Shareholders

Exhibit 99.2 Health Assurance Acquisition Corp. Releases Letter to Shareholders Cambridge, Massachusetts, October 27, 2022 – Health Assurance Acquisition Corp. (Nasdaq: HAAC) Chairman and Chief Executive Officer Hemant Taneja today issued the following letter: Dear Health Assurance Acquisition Corp. Shareholders, On November 16, 2020, following the initial phase of the COVID-19 pandemic, we set ou

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 ¨ TRANSITION REPO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to HEALTH ASSURANCE ACQUISITION CORP. (Exact

Health Assurance Acquisition Corp. 20 University Road Cambridge, Massachusetts 02138 August 23, 2022

Health Assurance Acquisition Corp. 20 University Road Cambridge, Massachusetts 02138 August 23, 2022 VIA EDGAR Howard Efron Wilson Lee Division of Corporation Finance Office of Real Estate & Construction U.S. Securities and Exchange Commission 100 F Street, NE Washington, D.C. 20549-3561 Re: Health Assurance Acquisition Corp. Form 10-K for the year ended December 31, 2021 Filed March 30, 2022 File

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One)

Table of Contents ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One)

Table of Contents ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 30, 2022 HEALTH ASSURANCE ACQUISITION CORP. (Exact name of registrant as specified in its charter) Delaware 001-39702 85-2899745 (State or other jurisdiction of incorpor

Letter Agreement, dated as of April 5, 2022, between the Company and Mark Allen (incorporated by reference to the Company’s Current Report on Form 8-K filed with the SEC on April 5, 2022).

Exhibit 10.1 April 5, 2022 Health Assurance Acquisition Corp. 20 University Road Cambridge, Massachusetts 02138 Re: CFO Appointment Ladies and Gentlemen: This letter (this ?Letter Agreement?) , dated as of the date hereof and effective as of March 30, 2022, is being delivered to you in connection with your appointment as Chief Financial Officer of Health Assurance Acquisition Corp., a Delaware cor

Indemnity Agreement, dated as of April 5, 2022, between the Company and Mark Allen (incorporated by reference to the Company’s Current Report on Form 8-K filed with the SEC on April 5, 2022).

Exhibit 10.2 INDEMNITY AGREEMENT THIS INDEMNITY AGREEMENT (this ?Agreement?) is made as of April 5, 2022, effective as of March 30, 2022, by and between Health Assurance Acquisition Corp., a Delaware corporation (the ?Company?), and the undersigned (?Indemnitee?). RECITALS WHEREAS, highly competent persons have become more reluctant to serve publicly-held corporations as directors, officers or in

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTI

Table of Contents ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment No. 2 (Mark One)

Table of Contents ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

HAAC / Health Assurance Acquisition Corp / Sculptor Capital LP - SC 13G Passive Investment

SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* HEALTH ASSURANCE ACQUISITION CORP. (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 42226W109 (CUSIP Number) February 24, 2022 (Date of Event Which Requires Filing of this Statement) Check the approp

Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 16, 2022 HEALTH ASSURANCE ACQUISITION CORP. (Exact name of registrant as specified in its charter) Delaware 001-39702 85-2899745 (State or other jurisdiction of incorporation or or

HAAC / Health Assurance Acquisition Corp / HAAC Sponsor, LLC - SC 13G/A Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934* (Amendment No. 1) Health Assurance Acquisition Corp. (Name of Issuer) CLASS A COMMON STOCK, PAR VALUE $0.0001 PER SHARE (Title of Class of Securities) 42226W109 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the Appropriate

HAAC / Health Assurance Acquisition Corp / Weiss Asset Management LP Passive Investment

SC 13G 1 haac13g31dec2021.htm =============================================================================== UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.)* HEALTH ASSURANCE ACQUISITION CORP. - (Name of Issuer) Class A Common Stock, $0.0001 par value per share - (Title of Class of Securities) 42226W109

HAAC / Health Assurance Acquisition Corp / INTEGRATED CORE STRATEGIES (US) LLC Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (AMENDMENT NO. 2) HEALTH ASSURANCE ACQUISITION CORP. (Name of Issuer) CLASS A COMMON STOCK, PAR VALUE $0.0001 PER SHARE (Title of Class of Securities) 42226W109 (CUSIP Number) DECEMBER 31, 2021 (Date of event which requires filing of this statement) Check the appropriate b

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No.3) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 ☐ TRANSITION REPOR

Table of Contents ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No.2) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 ☐ TRANSITION REPOR

Table of Contents ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment No. 1 (Mark One)

Table of Contents ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 22, 2021 HEALTH ASSURANCE ACQUISITION CORP. (Exact name of registrant as specified in its charter) Delaware 001-39702 85-2899745 (State or other jurisdiction of incorporation or or

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One)

Table of Contents ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 28, 2021 HEALTH ASSURANCE ACQUISITION CORP. (Exact name of registrant as specified in its charter) Delaware 001-39702 85-2899745 (State or other jurisdiction of incorporation)

Indemnity Agreement, dated as of August 19, 2021, between the Company and Michelle Brown (incorporated by reference to the Company's Current Report on Form 8-K filed with the SEC on August 20, 2021).

Exhibit 10.2 INDEMNITY AGREEMENT THIS INDEMNITY AGREEMENT (this ?Agreement?) is made as of August 19, 2021, by and between Health Assurance Acquisition Corp., a Delaware corporation (the ?Company?), and the undersigned (?Indemnitee?). RECITALS WHEREAS, highly competent persons have become more reluctant to serve publicly-held corporations as directors, officers or in other capacities unless they a

Letter Agreement, dated as of August 19, 2021, between the Company and Michelle Brown (incorporated by reference to the Company's Current Report on Form 8-K filed with the SEC on August 20, 2021).

Exhibit 10.1 August 19, 2021 Health Assurance Acquisition Corp. 20 University Road Cambridge, Massachusetts 02138 Re: CFO Appointment Ladies and Gentlemen: This letter (this ?Letter Agreement?) is being delivered to you in connection with your appointment as Chief Financial Officer of Health Assurance Acquisition Corp., a Delaware corporation (the ?Company?). Reference is made to the Company?s ini

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 20, 2021 (August 17, 2021) HEALTH ASSURANCE ACQUISITION CORP. (Exact name of registrant as specified in its charter) Delaware 001-39702 85-2899745 (State or other juris

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One)

Table of Contents ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Health Assurance Acquisition Corp. (Exact n

Health Assurance Acquisition Corp. Receives Expected Notice From Nasdaq Regarding Delayed Quarterly Report

Exhibit 99.1 Health Assurance Acquisition Corp. Receives Expected Notice From Nasdaq Regarding Delayed Quarterly Report San Francisco ? June 4, 2021 ? Health Assurance Acquisition Corp. (Nasdaq: HAACU) (the ?Company?) today announced that, on May 28, 2021, it received a notice (?Notice?) from the Listing Qualifications Department of The Nasdaq Stock Market (?Nasdaq?) stating that the Company is no

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 28, 2021 HEALTH ASSURANCE ACQUISITION CORP. (Exact name of registrant as specified in its charter) Delaware 001-39702 85-2899745 (State or other jurisdiction of incorporat

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No.1) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 ¨ TRANSITION REPOR

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No.1) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to HEALTH ASSURANCE ACQUISITION CORP. (Exact n

Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 14, 2021 HEALTH ASSURANCE ACQUISITION CORP. (Exact name of registrant as specified in its charter) Delaware 001-39702 85-2899745 (State or other jurisdiction of incorporat

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING 001-39702 Commission File Number (Check One): ? Form 10-K ? Form 20-F ? Form 11-K x Form 10-Q and Form 10-D ? Form N-SAR ? Form N-CSR For Period Ended: March 31, 2021 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 11-K ? Transition Report on

Code of Ethics.(2)

Exhibit 14.1 HEALTH ASSURANCE ACQUISITION CORP. CODE OF ETHICS 1. Introduction The Board of Directors of Health Assurance Acquisition Corp. has adopted this code of ethics (the ?Code?), which is applicable to all directors, officers and employees, to: ? promote honest and ethical conduct, including the ethical handling of actual or apparent conflicts of interest between personal and professional r

Annual Report - FORM 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to HEALTH ASSURANCE ACQUISITION CORP. (Exact name of registrant a

JOINT FILING AGREEMENT

EX-99.A EXHIBIT A JOINT FILING AGREEMENT In accordance with Rule 13d-1(k) of the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a Statement on Schedule 13G (including any and all amendments thereto) with respect to the Class A common stock, par value $0.0001 per share, of Health Assurance Acquisition Corp. and further agree that

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. ) * HEALTH ASSURANCE ACQUISITION CORP. (Name of Issuer) Class A Common Stock, par value $0.0001 per share (T

SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. ) * HEALTH ASSURANCE ACQUISITION CORP. (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 42226W208** (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the app

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934* Health Assurance Acquisition Corp. (Name of Issuer) CLASS A COMMON STOCK, PAR VALUE $0.0001 PER SHARE (Title of Class of S

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934* Health Assurance Acquisition Corp. (Name of Issuer) CLASS A COMMON STOCK, PAR VALUE $0.0001 PER SHARE (Title of Class of Securities) 42226W109 (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the Appropriate Box to Designate t

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (AMENDMENT NO. 1) HEALTH ASSURANCE ACQUISITION CORP. (Name of Issuer) CLASS A COMMON STOCK, PAR VALUE $0.0001 PER SHARE (Ti

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (AMENDMENT NO. 1) HEALTH ASSURANCE ACQUISITION CORP. (Name of Issuer) CLASS A COMMON STOCK, PAR VALUE $0.0001 PER SHARE (Title of Class of Securities) 42226W109 (CUSIP Number) DECEMBER 31, 2020 (Date of event which requires filing of this statement) Check the appropriate b

Health Assurance Acquisition Corp. Announces the Separate Trading of its shares of Class A Common Stock and Warrants Commencing January 4, 2021

Exhibit 99.1 Health Assurance Acquisition Corp. Announces the Separate Trading of its shares of Class A Common Stock and Warrants Commencing January 4, 2021 San Francisco – December 30, 2020 – Health Assurance Acquisition Corp. (Nasdaq: HAACU) (the “Company”) today announced that, commencing January 4, 2021, holders of the SAILSM securities sold in the Company’s initial public offering of SAILSM s

Financial Statements and Exhibits, Other Events - FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 30, 2020 HEALTH ASSURANCE ACQUISITION CORP. (Exact name of registrant as specified in its charter) Delaware 001-39702 85-2899745 (State or other jurisdiction of incor

Quarterly Report - FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Health Assurance Acquisition Corp. (Exa

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits - FORM 8-K/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 12, 2020 HEALTH ASSURANCE ACQUISITION CORP. (Exact name of registrant as specified in its charter) Delaware 001-39702 85-2899745 (State or other jurisdiction of inc

HEALTH ASSURANCE ACQUISITION CORP.

Exhibit 99.1 HEALTH ASSURANCE ACQUISITION CORP. Report of Independent Registered Public Accounting Firm F-2 Balance Sheet as of November 17, 2020 F-3 Notes to Balance Sheet F-4 REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM To the Stockholders and the Board of Directors of Health Assurance Acquisition Corp. Opinion on the Financial Statement We have audited the accompanying balance sheet

Financial Statements and Exhibits, Other Events - FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 17, 2020 HEALTH ASSURANCE ACQUISITION CORP. (Exact name of registrant as specified in its charter) Delaware 001-39702 85-2899745 (State or other jurisdiction of incor

Passive Investment -

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 HEALTH ASSURANCE ACQUISITION CORP. (Name of Issuer) CLASS A COMMON STOCK, PAR VALUE $0.0001 PER SHARE (Title of Class of Securities) 42226W208** (CUSIP Number) NOVEMBER 13, 2020 (Date of event which requires filing of this statement) Check the appropriate box to designate

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 12, 2020 HEALTH ASSURANCE ACQUISITION CORP. (Exact name of registrant as specified in its charter) Delaware 001-39702 85-2899745 (State or other jurisdiction of incor

Letter Agreement among the Company, the Sponsor, the Foundation and the Company’s officers and directors(1)

Exhibit 10.4 November 12, 2020 Health Assurance Acquisition Corp. 20 University Road Cambridge, Massachusetts 02138 Morgan Stanley & Co. LLC 1585 Broadway New York, New York 10036 Re: Initial Public Offering Ladies and Gentlemen: This letter (this ?Letter Agreement?) is being delivered to you in accordance with the Underwriting Agreement (the ?Underwriting Agreement?) to be entered into by and bet

Second Amended and Restated Certificate of Incorporation(1)

Exhibit 3.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF HEALTH ASSURANCE ACQUISITION CORP. November 12, 2020 Health Assurance Acquisition Corp., a corporation organized and existing under the laws of the State of Delaware (the ?Corporation?), DOES HEREBY CERTIFY AS FOLLOWS: 1. The name of the Corporation is ?Health Assurance Acquisition Corp.?. The original certificate of incorporation of

Warrant Agreement between Continental Stock Transfer & Trust Company and the Company(1)

Exhibit 4.1 WARRANT AGREEMENT between HEALTH ASSURANCE ACQUISITION CORP. and CONTINENTAL STOCK TRANSFER & TRUST COMPANY THIS WARRANT AGREEMENT (this ?Agreement?), dated as of November 12, 2020, is by and between Health Assurance Acquisition Corp., a Delaware corporation (the ?Company?), and Continental Stock Transfer & Trust Company, a New York limited purpose trust company, as warrant agent (in s

Registration and Shareholder Rights Agreement between the Company, the Sponsor, the Foundation and certain directors of the Company(1)

Exhibit 10.3 REGISTRATION AND STOCKHOLDER RIGHTS AGREEMENT THIS REGISTRATION AND STOCKHOLDER RIGHTS AGREEMENT (this ?Agreement?), dated as of November 12, 2020, is made and entered into by and among Health Assurance Acquisition Corp., a Delaware corporation (the ?Company?), HAAC Sponsor, LLC, a Delaware limited liability company (the ?Sponsor?), Health Assurance Economy Foundation (the ?Foundation

Investment Management Trust Account Agreement between Continental Stock Transfer & Trust Company and the Company(1)

Exhibit 10.2 INVESTMENT MANAGEMENT TRUST AGREEMENT This Investment Management Trust Agreement (this ?Agreement?) is made effective as of November 12, 2020 by and between Health Assurance Acquisition Corp., a Delaware corporation (the ?Company?), and Continental Stock Transfer & Trust Company, a New York corporation (the ?Trustee?). WHEREAS, the Company?s registration statement on Form S-1, No. 333

Private Placement Warrants Purchase Agreement between the Company, the Sponsor, and certain directors of the Company(1)

Exhibit 10.1 PRIVATE PLACEMENT WARRANTS PURCHASE AGREEMENT THIS PRIVATE PLACEMENT WARRANTS PURCHASE AGREEMENT, dated as of November 12, 2020 (as it may from time to time be amended and including all exhibits referenced herein, this ?Agreement?), is entered into by and between Health Assurance Acquisition Corp., a Delaware corporation (the ?Company?), HAAC Sponsor, LLC, a Delaware limited liability

Underwriting Agreement between the Company and Morgan Stanley Co. LLC(1)

Exhibit 1.1 50,000,000 SAILSM Securities Health Assurance Acquisition Corp. UNDERWRITING AGREEMENT November 12, 2020 Morgan Stanley & Co. LLC 1585 Broadway New York, New York 10036 As Representative of the several Underwriters listed in Schedule I to the Agreement Dear Ladies and Gentlemen: 1. Introductory. Health Assurance Acquisition Corp., a Delaware corporation (the ?Company?), agrees with the

Administrative Services Agreement between the Company and the Sponsor(1)

Exhibit 10.5 HEALTH ASSURANCE ACQUISITION CORP. 20 University Road Cambridge, MA 02138 November 12, 2020 HAAC Sponsor, LLC 20 University Road Cambridge, MA 02138 Re: Administrative Support Agreement Ladies and Gentlemen: This letter agreement by and between Health Assurance Acquisition Corp. (the ?Company?) and HAAC Sponsor, LLC (?Sponsor?), dated as of the date hereof, will confirm our agreement

Amended and Restated Bylaws(1)

Exhibit 3.2 AMENDED AND RESTATED BY LAWS OF HEALTH ASSURANCE ACQUISITION CORP. (THE ?CORPORATION?) Article I OFFICES Section 1.1 Registered Office. The registered office of the Corporation within the State of Delaware shall be located at either (a) the principal place of business of the Corporation in the State of Delaware or (b) the office of the corporation or individual acting as the Corporatio

$500,000,000 Health Assurance Acquisition Corp. 50,000,000 SAILSM (Stakeholder Aligned Initial Listing) Securities

TABLE OF CONTENTS ?Filed Pursuant to Rule 424(b)(4) ? Registration No. 333-249667? PROSPECTUS $500,000,000 Health Assurance Acquisition Corp. 50,000,000 SAILSM (Stakeholder Aligned Initial Listing) Securities Health Assurance Acquisition Corp. is a newly organized blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or

- 8-A12B

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 HEALTH ASSURANCE ACQUISITION CORP.

- S-1/A

TABLE OF CONTENTS As filed with the United States Securities and Exchange Commission on November 12, 2020 under the Securities Act of 1933, as amended.

Amended and Restated Certificate of Incorporation

Exhibit 3.2 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF HEALTHCARE ASSURANCE ACQUISITION CORP. Adopted in accordance with the provisions of Section 241 and Section 245 of the General Corporation Law of the State of Delaware Healthcare Assurance Acquisition Corp., a corporation organized and existing under the laws of the State of Delaware (the “Corporation”), hereby certifies as follows:

Form of Second Amended and Restated Certificate of Incorporation.

Exhibit 3.3 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF HEALTH ASSURANCE ACQUISITION CORP. November 12, 2020 Health Assurance Acquisition Corp., a corporation organized and existing under the laws of the State of Delaware (the “Corporation”), DOES HEREBY CERTIFY AS FOLLOWS: 1. The name of the Corporation is “Health Assurance Acquisition Corp.”. The original certificate of incorporation of

-

Health Assurance Acquisition Corp. 20 University Road Cambridge, Massachusetts 02138 November 12, 2020 VIA EDGAR Division of Corporation Finance Securities and Exchange Commission 100 F Street, NE Washington, D.C. 20549 Re: Health Assurance Acquisition Corp. Amendment No. 2 to Form S-1 filed November 9, 2020 CIK No. 0001824013 Ladies and Gentlemen: This letter is in response to the comment of the

-

November 10, 2020 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.

-

Health Assurance Acquisition Corp. 20 University Road Cambridge, Massachusetts 02138 November 10, 2020 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: Health Assurance Acquisition Corp. Registration Statement on Form S-1 File No. 333-249667 Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amen

Form of Amended and Restated Certificate of Incorporation.

Exhibit 3.2 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF HEALTH ASSURANCE ACQUISITION CORP. November , 2020 Health Assurance Acquisition Corp., a corporation organized and existing under the laws of the State of Delaware (the “Corporation”), DOES HEREBY CERTIFY AS FOLLOWS: 1. The name of the Corporation is “Health Assurance Acquisition Corp.”. The original certificate of incorporation of t

- S-1/A

TABLE OF CONTENTS As filed with the United States Securities and Exchange Commission on November 9, 2020 under the Securities Act of 1933, as amended.

-

Health Assurance Acquisition Corp. 20 University Road Cambridge, Massachusetts 02138 November 9, 2020 VIA EDGAR Division of Corporation Finance Securities and Exchange Commission 100 F Street, NE Washington, D.C. 20549 Re: Health Assurance Acquisition Corp. Form S-1 filed October 26, 2020 CIK No. 0001824013 Ladies and Gentlemen: This letter is in response to the comment of the Staff of the Divisio

Form of Registration and Stockholder Rights Agreement among the Registrant, the Sponsor, the Foundation and the Holders signatory thereto.*

Exhibit 10.2 REGISTRATION AND STOCKHOLDER RIGHTS AGREEMENT THIS REGISTRATION AND STOCKHOLDER RIGHTS AGREEMENT (this “Agreement”), dated as of November , 2020, is made and entered into by and among Health Assurance Acquisition Corp., a Delaware corporation (the “Company”), HAAC Sponsor, LLC, a Delaware limited liability company (the “Sponsor”), Health Assurance Economy Foundation (the “Foundation”)

Form of Underwriting Agreement.*

Exhibit 1.1 50,000,000 SAILSM Securities Health Assurance Acquisition Corp. UNDERWRITING AGREEMENT [●], 2020 Morgan Stanley & Co. LLC 1585 Broadway New York, New York 10036 As Representative of the several Underwriters listed in Schedule I to the Agreement Dear Ladies and Gentlemen: 1. Introductory. Health Assurance Acquisition Corp., a Delaware corporation (the “Company”), agrees with the several

Form of Investment Management Trust Agreement between Continental Stock Transfer & Trust Company and the Registrant.*

Exhibit 10.1 INVESTMENT MANAGEMENT TRUST AGREEMENT This Investment Management Trust Agreement (this “Agreement”) is made effective as of November , 2020 by and between Health Assurance Acquisition Corp., a Delaware corporation (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation (the “Trustee”). WHEREAS, the Company’s registration statement on Form S-1, No. 333-2

Securities Certificate.*

EX-4.1 5 tm2031762d7ex4-1.htm EXHIBIT 4.1 Exhibit 4.1 NUMBER SAILSM securities U- SEE REVERSE FOR CERTAIN DEFINITIONS CUSIP [] HEALTH ASSURANCE ACQUISITION CORP. SAILSM (STAKEHOLDER ALIGNED INITIAL LISTING) SECURITY CONSISTING OF ONE SHARE OF CLASS A COMMON STOCK AND ONE-FOURTH OF ONE WARRANT TO PURCHASE ONE SHARE OF CLASS A COMMON STOCK THIS CERTIFIES THATis the owner of SAILSM securities. Each S

Form of Letter Agreement between the Registrant, the Sponsor and each Director and Executive Officer of the Registrant.*

Exhibit 10.8 November , 2020 Health Assurance Acquisition Corp. 20 University Road Cambridge, Massachusetts 02138 Morgan Stanley & Co. LLC 1585 Broadway New York, New York 10036 Re: Initial Public Offering Ladies and Gentlemen: This letter (this “Letter Agreement”) is being delivered to you in accordance with the Underwriting Agreement (the “Underwriting Agreement”) to be entered into by and betwe

Form of Private Placement Warrants Purchase Agreement between the Registrant and the Sponsor.*

Exhibit 10.3 PRIVATE PLACEMENT WARRANTS PURCHASE AGREEMENT THIS PRIVATE PLACEMENT WARRANTS PURCHASE AGREEMENT, dated as of November , 2020 (as it may from time to time be amended and including all exhibits referenced herein, this “Agreement”), is entered into by and between Health Assurance Acquisition Corp., a Delaware corporation (the “Company”), HAAC Sponsor, LLC, a Delaware limited liability c

By Laws.*

EXHIBIT 3.3 BYLAWS OF HEALTHCARE ASSURANCE ACQUISITION CORP. a Delaware corporation Article I OFFICES Section 1. Registered Office. The registered office of the corporation in the State of Delaware shall be located at 251 Little Falls Drive, Wilmington, New Castle County, Delaware 19808. The name of the corporation’s registered agent at such address shall be Corporation Service Company. The regist

Form of Amended and Restated By Laws.*

EXHIBIT 3.4 AMENDED AND RESTATED BY LAWS OF HEALTH ASSURANCE ACQUISITION CORP. (THE “CORPORATION”) Article I OFFICES Section 1.1 Registered Office. The registered office of the Corporation within the State of Delaware shall be located at either (a) the principal place of business of the Corporation in the State of Delaware or (b) the office of the corporation or individual acting as the Corporatio

Form of Indemnity Agreement.*

Exhibit 10.4 INDEMNITY AGREEMENT THIS INDEMNITY AGREEMENT (this “Agreement”) is made as of , 2020, by and between Health Assurance Acquisition Corp., a Delaware corporation (the “Company”), and the undersigned (“Indemnitee”). RECITALS WHEREAS, highly competent persons have become more reluctant to serve publicly-held corporations as directors, officers or in other capacities unless they are provid

- S-1/A

As filed with the United States Securities and Exchange Commission on November 6, 2020 under the Securities Act of 1933, as amended.

Specimen Warrant Certificate.*

Exhibit 4.3 Form of Warrant Certificate [FACE] Number Warrants THIS WARRANT SHALL BE VOID IF NOT EXERCISED PRIOR TO THE EXPIRATION OF THE EXERCISE PERIOD PROVIDED FOR IN THE WARRANT AGREEMENT DESCRIBED BELOW HEALTH ASSURANCE ACQUISITION CORP. Incorporated Under the Laws of the State of Delaware CUSIP [] Warrant Certificate This Warrant Certificate certifies that , or registered assigns, is the reg

Specimen Class A Common Stock.*

Exhibit 4.2 NUMBER C- SHARES SEE REVERSE FOR CERTAIN DEFINITIONS CUSIP [] HEALTH ASSURANCE ACQUISITION CORP. INCORPORATED UNDER THE LAWS OF THE STATE OF DELAWARE CLASS A COMMON STOCK This Certifies that is the owner of FULLY PAID AND NON-ASSESSABLE SHARES OF THE PAR VALUE OF $0.0001 EACH OF THE CLASS A COMMON STOCK OF HEALTH ASSURANCE ACQUISITION CORP. (THE “CORPORATION”) transferable on the books

Form of Administrative Services Agreement between the Registrant and the Sponsor.*

Exhibit 10.5 HEALTH ASSURANCE ACQUISITION CORP. 20 University Road Cambridge, MA 02138 , 2020 HAAC Sponsor, LLC 20 University Road Cambridge, MA 02138 Re: Administrative Support Agreement Ladies and Gentlemen: This letter agreement by and between Health Assurance Acquisition Corp. (the “Company”) and HAAC Sponsor, LLC (“Sponsor”), dated as of the date hereof, will confirm our agreement that, comme

Form of Warrant Agreement between Continental Stock Transfer & Trust Company and the Registrant.*

Exhibit 4.4 WARRANT AGREEMENT between HEALTH ASSURANCE ACQUISITION CORP. and CONTINENTAL STOCK TRANSFER & TRUST COMPANY THIS WARRANT AGREEMENT (this “Agreement”), dated as of November , 2020, is by and between Health Assurance Acquisition Corp., a Delaware corporation (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation, as warrant agent (in such capacity, the “W

-

Health Assurance Acquisition Corp. 20 University Road Cambridge, Massachusetts 02138 October 26, 2020 VIA EDGAR Division of Corporation Finance Securities and Exchange Commission 100 F Street, NE Washington, D.C. 20549 Re: Health Assurance Acquisition Corp. Draft Registration Statement on Form S-1 Submitted September 28, 2020 CIK No. 0001824013 Ladies and Gentlemen: This letter is in response to t

Promissory Note, dated as of September 24, 2020, between the Registrant and the Sponsor.*

Exhibit 10.6 THIS PROMISSORY NOTE (“NOTE”) HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE COMPANY

Certificate of Incorporation.*

Exhibit 3.1 CERTIFICATE OF INCORPORATION OF HEALTHCARE ASSURANCE ACQUISITION CORP. ARTICLE ONE The name of the corporation is Healthcare Assurance Acquisition Corp. ARTICLE TWO The address of the corporation’s registered office in the State of Delaware is 251 Little Falls Drive, Wilmington, New Castle County, Delaware 19808. The name of the registered agent of the corporation at such address is Co

Securities Subscription Agreement, dated September 24, 2020, between the Registrant and the Sponsor.*

Exhibit 10.7 Healthcare Assurance Acquisition Corp. 20 University Road Cambridge, MA 02138 September 24, 2020 General Catalyst Group X - Early Venture, L.P. 20 University Road Cambridge, MA 02138 Health Assurance Economy Foundation c/o Commure, Inc. 376 Brannan Street San Francisco, CA 94107 RE: Securities Subscription Agreement Ladies and Gentlemen: We are pleased to accept the offer (i) General

Power of Attorney (included on signature page to the initial filing of the Registration Statement).*

TABLE OF CONTENTS As filed with the United States Securities and Exchange Commission on October 26, 2020 under the Securities Act of 1933, as amended.

-

TABLE OF CONTENTS This is a confidential draft submission to the United States Securities and Exchange Commission on September 28, 2020 under the Securities Act of 1933, as amended.